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THERE IS good evidence to suggest that,
following neoplastic transformation, there
are changes at the cell surface, particu-
larlyinthe glycosylated components ofthe
plasma membrane (Cook & Stoddart,
1973; Hakomori, 1975; Hynes, 1976),
some but not necessarily all of which may
be a requirement for the transformed
state. One such candidate was described
by Price & Stoddart (1976), who demon-
strated by isoelectric focusing that neutral
detergent extracts of plasma membranes
from a variety ofexperimental and human
tumours contained a glycoprotein of pl
4 0 which was not present on plasma mem-
branes ofnormal cells, but was present on
intracytoplasmic membranes of regener-
ating rat liver. It was suggested that in the
malignant cell a glycoprotein which occurs
normally as an intracellular membrane
component appeared at the cell surface
where it was characteristic of, but not
necessarily functional in, the expression of
malignancy. Using a different system,
Bramwell & Harris (1978a) demonstrated
the presence in detergent extracts of
tumour-cell ghosts of a marker for malig-
nancy. This marker was found in a variety
of different mouse and human tumour
cells and in somatic cell hybrids oftumour
and normal diploid cells. This marker dis-
appeared from the plasma membrane
when malignancy was suppressed by fusion
with non-malignant cells, but reappeared
in the independently derived segregant
tumours subsequently generated from the
hybrid population. This marker was a
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glycoprotein with an isoelectric point of
pl 4'0, suggesting that the materials
detected by Price & Stoddart (1976) and
Bramwell & Harris (1978a) were similar.
In this communication we examine the
possibility that the presence of the pI 4 0
glycoprotein in plasma membranes de-
rived from tissue samples is a marker for
the presence of malignant cells.
Tissue obtained by transurethral resec-
tion of prostate mass to relieve urinary
retention was coded, and plasma mem-
branes were prepared from the tissue by
homogenization in 10-3M ZnCl2. Un-
degraded tissue and cell nuclei were re-
moved by an initial centrifugation at
1500 g for 10 min, and extranuclear mem-
branes were recovered from the super-
natant by centrifugation at 105,000 g for
90 min. Plasma membranes were prepared
from this high-speed pellet by the 2-phase
aqueous polymer system of Brunette &
Till (1971) and were extracted overnight
at + 4°C with 0.5% NP40 (BDH Ltd,
Poole) in phosphate-buffered saline (pH
7.3). Detergent-insoluble material was
removed by centrifugation at 105,000 g
for 90 min. Soluble material was analysed
by isoelectric focusing in 5% polyacryl-
amide gels by the method of Wrigley
(1968) containing 0.5% NP40 and 2%
Ampholines, pH range 2-5-10 (LKB Ltd,
Uppsala, Sweden). Protein bands were
visualized with Coomassie Blue following
fixation in 5% trichloroacetic acid and
washing in deionized water to remove
detergent. Gel rods were scanned at
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TABLE.-Comparison of results of histo-
logical examination ofprostate tissue sec-
tions with the presence of pI 4 0 glyco-
protein
Tissue
sample
D34
W33
B31
U18
A33
H33
D33
C33
D37
H14
G33
B32
W34
S12
T22
R23
P1l
M38
J10
A31
D1O
A43
H34
% pl 4-0
glycoprotein*
0-0
00
0.0
00
0.0
00
0.0
0.0
0.0
0.0
0-1
0-7
0-8
3-8
4 0
4-1
4.9
4.9
5-3
6-0
6-5
8-5
8-5
Histological
diagnosist
BPH
BPH
BPH
BPH
BPH
BPH
BPH
BPH
BPH
BPH
BPH
BPH
BPH
Ca
Ca
Ca
Ca
Ca
Ca
Ca
Ca
Ca
Ca
* p1 4 0 glycoprotein estimated by planimetry of
gel scanner traces. Area under pl 4-0 peak is ex-
pressed as % of total area under the trace.
t BPH=Benign prostatic hypertrophy; Ca=
Prostatic adenocarcinoma.
530 nm in a Gilford Model 250 spectro-
photometer. pH gradients were extra-
polated from control gels after sectioning,
elution into deionized water and measure-
ment ofthe pH ofthe ampholyte solution.
The coded samples were assessed for the
presence of a distinct Coomassie Blue
staining band at pH 4 0. The area under
this peak was quantitated by planimetry
and expressed as a percentage of the total
area ofthe trace. Results from 23 separate
tissue samples are detailed in the Table.
All 10 tissue samples classed as malignant
prostatic adenocareinoma by the patholo-
gist showed the presence of a sharply
defined protein peak at pH 4 0 in the iso-
electric focusing gels. In contrast, of the
13 samples classified as benign prostatic
hypertrophy (BPH) only 3 possessed a
Coomassie Blue staining peak at pH 4*0
(samples G33, W34 and B32). In these
cases, however, the percentage of pl 4 0
protein as estimated by planimetry were
much lower (0.1-0-8) than in the definite
carcinoma tissue (3-8-8-5).
There are a number ofpossible explana-
tions for the 3 false positives in the BPH
group. It is possible that the pl 4 0 protein
is not acancer-specific membrane material,
or that the low percentage ofthis material
reflects an artefact of the extraction and
analysis procedure. More probably, how-
ever, the amount of pl 4 0 protein may
reflect the number of tumour cells in the
tissue sample since it has previously been
shown that the pl 4.0 protein does not
reflect the degree of lymphocytic infiltra-
tion, vascularization of the tumour, num-
ber ofmitoses or a number ofother patho-
logical and immunological parameters
(Price & Stoddart, 1976). Again, these 3
false-positive results may in fact be valid
since Price & Stoddart (personal com-
munication) have shown that the pl 4 0
protein was detectable in the liver of
carcinogen-treated rats before carcinoma
in situ appeared, but as soon as foci of
metaplasia could be found. Similarly,
Else & Stoddart (personal communication)
have demonstrated an analogous pheno-
menon in the transition from benignity
to malignancy of spontaneous breast
tumours in dogs. Furthermore, there is a
high incidence of occult adenocarcinoma
associated with benign prostatic hyper-
trophy. In fact it has been estimated that
30% of men over the age of 50 years may
suffer from occult carcinoma (Franks,
1956).
These results support the concept (Price
& Stoddart, 1976; Bramwell & Harris,
1978a) that there is a single unifying
change at the plasma membrane of malig-
nant cells from a variety of tissues. It has
further been suggested that this change is
due to the appearance of a glycoprotein
with a pl of 4 0 which is intimately con-
cerned with glucose transport into the cell
(Bramwell & Harris, 1978b). Itis necessary
that these results be validated in a much
greater number of tumour systems and
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that the pl 4 0 glycoprotein be further
characterized before conclusions about its
ubiquity in cancer cells and its function
can be made.
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